Sotac Pharmaceuticals Fair Value

SOTAC • Use multi-model valuation to spot trade setups and log them in your Tickjournal

Fair Value Analysis Export

Export comprehensive fair value analysis for Sotac Pharmaceuticals. For full fundamentals and performance, visit SOTAC share price BSE .

P/E Based Valuation

Current EPS ₹0.42
Sector Avg P/E 14.5
Historical Avg P/E N/A
Average Fair Value
₹6.93

P/B Based Valuation

Book Value/Share ₹52.73
Sector Avg P/B 5.26
Historical Avg P/B N/A
Average Fair Value
₹178.22

Asset-Based Valuation

Book Value/Share ₹52.73
Liquidation Value/Share ₹78.91
Fair Value
₹52.73

Benjamin Graham Number

Current EPS ₹0.42
Book Value/Share ₹52.73
Graham Multiplier 22.5
Current P/E 13.23
Graham Criteria 1/3
Graham Number
₹22.32
Criteria Met: P/E ≤ 15

Analysis Overview

Methods Used
4
Data Year
2024
Sector
Healthcare

Available Data Sources: Financial statements, balance sheet data , sector comparisons.

Data Currency: Financial data is 2 years old (2024).

Peer Valuation Comparison

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Sanofi Consumer Healthca… SANOFICONR 42.5 26.57 ₹10,249
Sat Kartar Shopping SATKARTAR 25.87 4.93 ₹263
Accretion Pharmaceuticals ACCPL 11.62 1.75 ₹77
Par Drugs & Chemical PAR - 1.21 ₹132
Murae Organisor MURAE 3.0 0.21 ₹43

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.